Clascoterone 5% solution

DRUG2 trials

Sponsors

Cassiopea SpA

Conditions

Alopecia, Androgenetic

Phase 3

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

CompletedNCT05910450

Cassiopea SpAAlopecia, Androgenetic

Start: 2023-06-21End: 2026-01-26Updated: 2026-06-08

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

CompletedNCT05914805

Cassiopea SpAAlopecia, Androgenetic

Start: 2023-08-17End: 2025-07-16Updated: 2025-12-22